NCT01364623View on ClinicalTrials.gov

PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

February 29, 2012

Conditions
Female Sexual Dysfunction
Interventions
DRUG

Low dose testosterone nasal gel, single dose

Low dose testosterone nasal gel, single dose

DRUG

Medium dose testosterone nasal gel, single dose

Medium dose testosterone nasal gel, single dose

DRUG

High dose testosterone nasal gel, single dose

High dose testosterone nasal gel, single dose

DRUG

Medium dose testosterone nasal gel, multiple dose

Medium dose testosterone nasal gel, multiple dose

Trial Locations (1)

78705

Premier Research International LLC, Austin

Sponsors
All Listed Sponsors
lead

Acerus Pharmaceuticals Corporation

INDUSTRY

NCT01364623 - PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women | Biotech Hunter | Biotech Hunter